This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Sphingomonadaceae: NCBI 41297, [family]

Back to details

| alpha-4 proteobacteria| Sphingomonadaceae| Sphingomonadaceae Kosako et al. 2000| Sphingomonas group| Zymomonas group

  1. Environmental interactions: Sphingomonadaceae bacteria play important roles in environmental processes such as biodegradation, bioremediation, and pollutant removal. They are capable of degrading a diverse array of organic compounds, including aromatic hydrocarbons, pesticides, polycyclic aromatic hydrocarbons (PAHs), and industrial chemicals. Their ability to metabolize environmental pollutants can contribute to the detoxification and degradation of contaminants in soil, water, and air, thereby mitigating environmental pollution and promoting ecosystem health.

  2. Pathogenic potential: While most members of the family Sphingomonadaceae are considered non-pathogenic or opportunistic environmental bacteria, there have been rare reports of Sphingomonadaceae species causing infections in humans, particularly in immunocompromised individuals or those with underlying health conditions. Infections associated with Sphingomonadaceae bacteria include bloodstream infections, catheter-associated infections, respiratory infections, and infections associated with medical devices. However, such infections are uncommon, and Sphingomonadaceae bacteria are not typically regarded as major human pathogens.

  3. Biofilm formation: Sphingomonadaceae bacteria have the ability to form biofilms on biotic and abiotic surfaces, including medical devices such as catheters and implants. Biofilm formation can promote bacterial persistence, resistance to antimicrobial agents, and evasion of host immune responses, increasing the risk of device-associated infections. Understanding the mechanisms of biofilm formation by Sphingomonadaceae bacteria may aid in the development of strategies to prevent and treat biofilm-related infections.

  4. Immunomodulatory effects: Some studies suggest that exposure to Sphingomonadaceae bacteria or their components may have immunomodulatory effects on the host immune system. Certain Sphingomonadaceae species produce glycolipid antigens that can activate immune responses, particularly via interactions with specialized immune cells such as natural killer T (NKT) cells. These immunomodulatory effects may have implications for host-microbe interactions, allergic responses, and inflammatory diseases.

  5. Plant-microbe interactions: Sphingomonadaceae bacteria are commonly associated with plants and are known to form symbiotic relationships with plant roots. They can promote plant growth, enhance nutrient uptake, and protect plants from pathogens and environmental stressors. Understanding the interactions between Sphingomonadaceae bacteria and plants may have applications in agriculture, horticulture, and environmental remediation.

Other Sources for more information:

Legend

Sphingomonadaceae impacts on other bacteria of the same rank

R2SlopeTax NameParent Chart
0.5277444720268250.9697599411010742CaulobacteraceaeParent Taxa
0.25675192475318910.6224993467330933LysobacteraceaeParent Taxa

Other bacteria of the same rank impacting Sphingomonadaceae

R2SlopeTax NameParent Chart
0.431230694055557250.768605649471283CaulobacteraceaeParent Taxa
0.363331526517868040.7333244681358337LysobacteraceaeParent Taxa
0.347589015960693360.7072868943214417NitrobacteraceaeParent Taxa
0.291053742170333860.6197992563247681MethylobacteriaceaeParent Taxa
0.287779897451400760.6137744784355164BurkholderiaceaeParent Taxa
0.27093645930290220.5135101675987244OscillospiraceaeParent Taxa
0.26769414544105530.49594566226005554PseudomonadaceaeParent Taxa
0.26691299676895140.6299597024917603RhizobiaceaeParent Taxa
0.25490993261337280.6081464290618896MicrobacteriaceaeParent Taxa

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]